Target intelligence / Profile preview

Telomerase reverse transcriptase promoter (TERT promoter)

Target
TERT promoter
Molecular classification
DNA regulatory element, Promoter, Non-coding DNA
01

Overview

The Telomerase reverse transcriptase (TERT) promoter is a critical DNA regulatory element that controls the expression of the TERT gene, the rate-limiting component of the telomerase enzyme complex. In normal somatic cells, the TERT promoter is epigenetically silenced, leading to progressive telomere shortening and eventual replicative senescence [1]. However, in approximately 90% of human cancers, the promoter is reactivated, enabling cells to maintain telomere length and achieve replicative immortality [2]. This reactivation is frequently driven by highly recurrent somatic point mutations (most notably C228T and C250T) that create de novo binding sites for ETS transcription factors [3]. Because the TERT promoter contains GC-rich sequences capable of forming G-quadruplex (G4) structures, it has become a significant therapeutic target [4]. Small molecules designed to stabilize these G4 structures can physically obstruct the transcriptional machinery, thereby suppressing telomerase activity and inducing apoptosis in cancer cells [5].

Other names
hTERT promoterTelomerase promoterTERTpTERT core promoter
02

Mechanism of action

Stabilization of G-quadruplex structures within the promoter region to physically block transcription factor binding and inhibit TERT gene transcription.

03

Biological functions

Regulation of gene expressionTelomere maintenanceCell immortalityReplicative lifespan control
04

Disease associations

CancerGlioblastomaMelanomaBladder cancerHepatocellular carcinomaThyroid cancer
05

Safety considerations

Off-target effects on other G-quadruplex-containing genomic regionsPotential toxicity to normal telomerase-dependent cells (e.g., hematopoietic stem cells, germ cells)Genomic instability due to widespread G-quadruplex stabilization
06

Interacting drugs

CX-5461

4 more in the full profile.

07

Biomarkers

TERT promoter mutations (C228T, C250T)TERT mRNA expression levelsTERT promoter methylation status

Beyond the preview

Go deeper on Telomerase reverse transcriptase promoter (TERT promoter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telomerase reverse transcriptase promoter (TERT promoter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call